Objective: To report atypical MRI patterns associated with POLR3A and POLR3B mutations.
used to orient the diagnostic process. [12] [13] [14] Patients without this pattern showing nonspecific hypomyelination are unlikely to carry mutations in POLR3A or POLR3B. 15 METHODS We performed a multi-institutional cross-sectional observational study of the clinical, radiologic, and molecular data of patients who fulfilled the following inclusion criteria: presence of recessive POLR3A or POLR3B mutations and absence of typical POLR3-related MRI features. 13, 14 We identified 8 patients from 7 nonconsanguineous families, all of Caucasian ethnicity, fulfilling these criteria. Five participants underwent POLR3A and POLR3B sequencing because they presented suggestive clinical features (hypodontia or dental abnormalities, short stature, and myopia, either associated or not). In 3 participants from 2 families, POLR3A and POLR3B mutations were identified by whole-exome sequencing (WES). For all families for which DNA was available, segregation was verified. Analysis for the potential pathogenicity of novel mutations was performed, including in silico analysis. For the novel splicing mutations, we sequenced cDNA when RNA was available.
MRI were reviewed collegially by our team. At least axial T2weighted and sagittal T1-or T2-weighted images were available.
Standard protocol approvals, registrations, and patient consents. The institutional review boards of each participating institution approved the use of clinical data for the study. ). Five mutations were intronic and affected a splice site or induced a new donor site. All new mutations were rare and predicted to be pathogenic by in silico tools [16] [17] [18] (table e-1 on the Neurology ® Web site at Neurology.org) besides for the c.-35C.G change, which had been reported in homozygous state in 2 out of over 60,000 participants (ExAC [http://exac.broadinstitute.org] [July 2015]) in patients 5 and 6. Segregation analysis in this family revealed that each of the parents carried one variant, and the healthy brother the paternal variant. WES failed to uncover other possible causal variants. Table 1 reports detailed information about the genetic status and mutations found in our cohort.
RESULTS
Clinical findings. Age at onset ranged from 6 weeks to 10 years (mean age at onset 52.3 months). The symptoms at disease onset were gait ataxia, dysarthria, and tremor in 3 participants (cases 1, 4, and 8). Two participants (cases 2 and 3) presented with spasticity and diplegic gait. The patient with the earliest disease onset, at 1.5 months, presented with failure to thrive (case 7). Clinical examination revealed ataxia of Table 1 POLR3A and POLR3B mutations identified in our cohort variable severity in all patients; cerebellar tremor was documented in 4 participants (cases 1, 2, 3, and 4); pyramidal signs and spasticity were present in 4 participants (cases 2, 3, 5, and 6). One patient had severe dystonic tremor (case 3) (table 1) .
Extraneurologic features were found in 6 patients. Specifically, 4 participants had hypodontia, delayed dentition, or other dental abnormalities (cases 1, 2, 3, and 8) suggestive of POLR3-related leukodystrophy. Two participants presented short stature (cases 1 and 7), and 4 had myopia (cases 4, 5, 6, and 7), both frequent findings in patients with mutations in POLR3A or POLR3B.
MRI findings. Mean age at the last MRI was 15 years (range 4-35 years). We identified 2 distinct MRI patterns (figures 1, 2, e-1, and e-2). Four participants, all with POLR3A mutations, presented a selective involvement of the corticospinal tracts, which was particularly evident at the level of the posterior limb of the internal capsule as T2-hyperintense signal (cases 1, 2, 3, and 8) (figures 1 and e-1). In the other 4 patients (2 with POLR3A and 2 with POLR3B mutations), moderate to severe cerebellar atrophy was variably associated with nonspecific T2-hyperintense white matter abnormalities, as specified below, or thinning of the corpus callosum (figures 2 and e-2) (cases 4, 5, 6, and 7). We documented focal, partially confluent, T2-hyperintense white matter abnormalities located in the deep frontal and parietal white matter, suggesting partial hypomyelination, in 5 participants (cases 2, 3, 4, 5, and 6), while the remaining 3 presented adequate myelination for age. DISCUSSION Our work broadens the MRI spectrum of POLR3-related leukodystrophy by describing 2 new MRI patterns in this disease that has been known as a hypomyelinating disorder. Our results indicate that diffuse hypomyelination is not an obligatory feature. We also documented the presence of 6 POLR3A and 2 POLR3B mutations not reported before in public databases. Interestingly, 5 of the 13 mutations in our cohort were noncoding, 4 predicted to affect splicing. Pathogenicity of the variant in the 59 untranslated region in patients 5 and 6 could not be unambiguously resolved as it had been reported in homozygous state in 2 participants in a large database. However, this variant is situated in a terminal oligopyrimidine tract (TOP). The change of a pyrimidine (C) for a purine (G) shortens the TOP, and it has been shown that deletions or substitutions in this region result in unregulated translation. 19, 20 Its effect might be mild, and homozygous carriers indeed might be unaffected, but in combination with a pathogenic mutation this variant could lead to disease. Segregation analysis and the absence of other possible causal variants in WES in this family indeed support a causal role for this variant, as does the identification of other families with isolated cerebellar atrophy.
A specific involvement of the corticospinal tracts, particularly evident at the level of the internal capsule as T2-hyperintense signal, was the most striking finding in a subgroup of patients. Interestingly, in typical cases, more commonly with POLR3B mutations, 12 the corticospinal tracts are usually one of the better myelinated structures.
The second pattern is the presence of cerebellar atrophy in the absence of diffuse hypomyelination. Cerebellar atrophy was previously known to be associated with POLR3A or POLR3B mutations in more than 80% of the participants, always in combination with diffuse hypomyelination. [12] [13] [14] 21 Focal, partly confluent T2-hyperintense white matter changes were present in some participants of both groups and located in the deep frontal and parietal white matter. The signal intensity of the abnormal areas corresponds to the one seen in hypomyelination, focal hypomyelination therefore being the most likely interpretation. These changes are obviously reminiscent of the classical MRI of 4H leukodystrophy, but sufficiently different to make a straightforward diagnosis challenging. Our results confirm white matter involvement when POLR3A or POLR3B is mutated; however, different pathogenic processes could be responsible for the variable and expanded MRI phenotypes of brain abnormalities associated with POLR3A or POLR3B mutations. Further insight into the role of POLR3 in myelin formation and maintenance as well as in axonal integrity is needed to explain the heterogeneity of the radiologic patterns. The diagnosis of POLR3-related leukodystrophy relies both on MRI findings and clinical signs. In our cohort, the presence of typical extraneurologic features oriented the clinicians towards the testing of POLR3A and POLR3B genes in 5 participants. Therefore, our study confirms the importance of the classical clinical criteria-particularly hypodontia and hypogonadotropic hypogonadism-in the diagnostic process of POLR3-related disorders, especially when cardinal MRI features are lacking. WES allowed the discovery of POLR3A and POLR3B mutations in the remaining cases, thus highlighting the role of next-generation sequencing in expanding the phenotypes of already known disorders.
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